#[first_name]
#[create_date]
#[first_name]
#[create_date]
IGF-I (1-3)
| Name | IGF-I (1-3) |
| Category | Growth Factors and Fragments |
| One Letter Code | GPE |
| Three Letter Code | {Gly}{Pro}{Glu} |
| Molecular Weight | 301.300 |
| Application | Di- and TripeptidesDiabetes |
| Tropea, Daniela, et al. "Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice." Proceedings of the National Academy of Sciences 106.6 (2009): 2029-2034. |
| Burgos‐Ramos, Emma, et al. "The N‐terminal tripeptide of insulin‐like growth factor‐I protects against β‐amyloid‐induced somatostatin depletion by calcium and glycogen synthase kinase 3β modulation." Journal of neurochemistry 109.2 (2009): 360-370. |
| Cacciatore, I., et al. "GPE and GPE analogues as promising neuroprotective agents." Mini reviews in medicinal chemistry 12.1 (2012): 13-23. |
| Shapira, Shlomo, et al. "Delayed peripheral administration of the N-terminal tripeptide of IGF-1 (GPE) reduces brain damage following microsphere induced embolic damage in young adult and aged rats." Neuroscience letters 454.1 (2009): 53-57. |